Lv1
20 积分 2024-06-20 加入
An Adhesion-Switchable Hydrogel Dressing for Painless Dressing Removal without Secondary Damage
15小时前
待确认
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA
25天前
已完结
The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
3个月前
已完结
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
3个月前
已完结
Modelled Economic Evaluation of Nivolumab for the Treatment of Second-Line Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer in Australia Using Both Partition Survival and Markov Models
3个月前
已完结
Modelled Economic Evaluation of Nivolumab for the Treatment of Second-Line Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer in Australia Using Both Partition Survival and Markov Models
3个月前
已完结
Cost–effectiveness of camrelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer
3个月前
已完结
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
4个月前
已完结
Cost–effectiveness of camrelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer
4个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)]
4个月前
已完结
皖公网安备34019202002308
